BACKGROUND: The ratio of pulmonary dead space to tidal volume (VD/VT) in acute respiratory distress syndrome (ARDS) is reported to be between 0.35 and 0.55. However, VD/VT has seldom been measured with consideration to the evolving pathophysiology of ARDS. METHODS: We made serial VD/VT measurements with 59 patients who required mechanical ventilation for > or = 6 days. We measured VD/VT within 24 h of the point at which the patient met the American-European Consensus Conference criteria for ARDS, and we repeated the VD/VT measurement on ARDS days 2, 3, and 6 with a bedside metabolic monitor during volume-regulated ventilation. We analyzed the changes in VD/VT over the 6-day period to determine whether VD/VT has a significant association with mortality. RESULTS: VD/VT was significantly higher in nonsurvivors on day 1 (0.61 +/- 0.09 vs 0.54 +/- 0.08, p < 0.05), day 2 (0.63 +/- 0.09 vs 0.53 +/- 0.09, p < 0.001), day 3 (0.64 +/- 0.09 vs 0.53 +/- 0.09, p < 0.001), and day 6 (0.66 +/- 0.09 vs 0.51 +/- 0.08, p < 0.001). CONCLUSION: In ARDS a sustained VD/VT elevation is characteristic of nonsurvivors, so dead-space measurements made beyond the first 24 hours may have prognostic value. Copyright 2004 Daedalus Enterprises
BACKGROUND: The ratio of pulmonary dead space to tidal volume (VD/VT) in acute respiratory distress syndrome (ARDS) is reported to be between 0.35 and 0.55. However, VD/VT has seldom been measured with consideration to the evolving pathophysiology of ARDS. METHODS: We made serial VD/VT measurements with 59 patients who required mechanical ventilation for > or = 6 days. We measured VD/VT within 24 h of the point at which the patient met the American-European Consensus Conference criteria for ARDS, and we repeated the VD/VT measurement on ARDS days 2, 3, and 6 with a bedside metabolic monitor during volume-regulated ventilation. We analyzed the changes in VD/VT over the 6-day period to determine whether VD/VT has a significant association with mortality. RESULTS: VD/VT was significantly higher in nonsurvivors on day 1 (0.61 +/- 0.09 vs 0.54 +/- 0.08, p < 0.05), day 2 (0.63 +/- 0.09 vs 0.53 +/- 0.09, p < 0.001), day 3 (0.64 +/- 0.09 vs 0.53 +/- 0.09, p < 0.001), and day 6 (0.66 +/- 0.09 vs 0.51 +/- 0.08, p < 0.001). CONCLUSION: In ARDS a sustained VD/VT elevation is characteristic of nonsurvivors, so dead-space measurements made beyond the first 24 hours may have prognostic value. Copyright 2004 Daedalus Enterprises
Authors: Richard H Kallet; Hanjing Zhuo; Kathleen D Liu; Carolyn S Calfee; Michael A Matthay Journal: Respir Care Date: 2013-12-31 Impact factor: 2.258
Authors: Elizabeth H Kim; Melissa Preissner; Richard P Carnibella; Chaminda R Samarage; Ellen Bennett; Marcio A Diniz; Andreas Fouras; Graeme R Zosky; Heather D Jones Journal: J Appl Physiol (1985) Date: 2017-06-08
Authors: Jeremy R Beitler; B Taylor Thompson; Michael A Matthay; Daniel Talmor; Kathleen D Liu; Hanjing Zhuo; Douglas Hayden; Roger G Spragg; Atul Malhotra Journal: Crit Care Med Date: 2015-05 Impact factor: 7.598
Authors: Hassan Siddiki; Marija Kojicic; Guangxi Li; Murat Yilmaz; Taylor B Thompson; Rolf D Hubmayr; Ognjen Gajic Journal: Crit Care Date: 2010-07-29 Impact factor: 9.097
Authors: Penny L Andrews; Benjamin Sadowitz; Michaela Kollisch-Singule; Joshua Satalin; Shreyas Roy; Kathy Snyder; Louis A Gatto; Gary F Nieman; Nader M Habashi Journal: Intensive Care Med Exp Date: 2015-06-09